Unichem Laboratories secures order disallowing ₹87.07 crore GST penalty
- Unichem Laboratories received an Order-in-Appeal disallowing a ₹87.07 crore GST penalty
- Interest liability of ₹6.58 crore was also disallowed by the Commissioner (Appeals Thane)
- The dispute involved allegations under Section 13 of the CGST Act, 2017
- Company plans to file further appeals despite the favorable ruling
- Management states no material impact on financial or operational activities

*this image is generated using AI for illustrative purposes only.
Unichem Laboratories received an Order-in-Appeal from the Commissioner (Appeals Thane) on September 18, 2026, disallowing a proposed penalty of ₹87.07 crore and interest liability of ₹6.58 crore related to cross-charge of common services.
The company disclosed the development in a filing under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The appeal concerned allegations of delayed tax payments and non-payment of interest under Section 13 of the CGST Act, 2017, and Rule 47 of the CGST Rules, 2017.
Regulatory Action Details
The Commissioner’s order addressed specific contraventions alleged by tax authorities. The key financial figures involved in the dispute are outlined below:
| Particulars | Amount |
|---|---|
| Penalty Disallowed | ₹87.07 crore |
| Interest Liability Disallowed | ₹6.58 crore |
| Relevant Acts | CGST Act, 2017; Maharashtra SGST Act, 2017 |
The penalty was originally levied under Section 74(1) and Section 122(2)(b) of the CGST Act, 2017, along with corresponding sections of the Maharashtra SGST Act, 2017. The interest liability stemmed from alleged delays in paying tax liabilities after the time of supply.
Next Steps
Unichem Laboratories stated that the order will have no material impact on its financial or operational activities. Despite the favorable outcome regarding the disallowance of the penalty and interest in this specific appeal instance, the company plans to file a further appeal within prescribed timelines. This indicates that the legal matter may not be fully concluded, as the company intends to pursue additional remedial steps based on legal advice.
The disclosure was signed by Pradeep Gautam Bhandari, Head – Legal & Company Secretary, and received by the stock exchanges after 2:00 pm on September 18, 2026.
Historical Stock Returns for Unichem Laboratories
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.35% | +2.44% | +0.44% | +74.29% | +7.74% | +99.27% |
What specific legal grounds is Unichem Laboratories planning to use in its further appeal, and how might this impact the final resolution timeline?
Could this favorable appellate order set a precedent for other pharmaceutical companies facing similar cross-charge of common services disputes under GST?
How might the resolution of this ₹93.65 crore liability affect Unichem's cash flow projections and working capital management in the upcoming fiscal quarters?


































